Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

TMUS stock ends higher — T-Mobile’s $3 billion debt move and an ad-watchdog decision tee up the next catalysts

TMUS stock ends higher — T-Mobile’s $3 billion debt move and an ad-watchdog decision tee up the next catalysts

New York, January 22, 2026, 20:53 (EST) — The market has closed. T-Mobile US shares climbed roughly 1% to $185.39 on Thursday. Following the market close, the company announced that its T-Mobile USA division will redeem $3 billion of 4.75% senior notes maturing in 2028, effective Feb. 1. (Business Wire) The debt move comes at a sensitive time for U.S.…
Palo Alto Networks stock edges higher — what PANW traders are watching next

Palo Alto Networks stock edges higher — what PANW traders are watching next

New York, January 22, 2026, 20:47 EST — Market closed Shares of Palo Alto Networks Inc (PANW) ticked up 0.44% to $182.27 on Thursday, riding the wave of a broader U.S. equity rally. The S&P 500 added 0.55%, while cybersecurity peers made bigger moves—Fortinet surged 2.47% and CrowdStrike gained 1.77%. (MarketWatch) The stock’s slip late in the week is significant…
Spotify stock price slips as Goldman upgrades SPOT and new AI “Prompted Playlist” rolls out

Spotify stock price slips as Goldman upgrades SPOT and new AI “Prompted Playlist” rolls out

New York, Jan 22, 2026, 20:40 (ET) — Market closed. Shares of Spotify Technology S.A. slipped 0.7%, ending Thursday at $498.42, after hitting an intraday range from $491.31 to $505.65. The stock kicked off the session at $505.50 but drifted lower by the close. (Businessinsider) The dip hands traders two new angles as they approach Friday: a bullish call from…
Accenture stock price climbs again — why ACN is back on traders’ screens

Accenture stock price climbs again — why ACN is back on traders’ screens

New York, Jan 22, 2026, 20:45 EST — Market closed. Accenture plc shares climbed 1.56% Thursday, closing at $285.09 and marking a second day of gains. Trading volume hit roughly 4.3 million shares, outpacing the recent average amid a generally firmer day for U.S. stocks. (MarketWatch) This matters now because investors want clarity on whether AI-driven work will boost demand…
AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week

AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week

New York, Jan 22, 2026, 8:47 PM EST — Market closed. AbbVie Inc (ABBV.N) shares climbed 0.9% Thursday, finishing at $218.11. The stock traded in a range from $214.81 to $219.04, with roughly 5.7 million shares exchanged. U.S. markets remain closed until Friday, leaving AbbVie’s next move more likely driven by pre-market developments — rate forecasts, policy news, and the…
AMD stock climbs as KeyBanc keeps $270 target, flags tight server CPU supply into 2026

AMD stock climbs as KeyBanc keeps $270 target, flags tight server CPU supply into 2026

New York, Jan 22, 2026, 20:19 EST KeyBanc maintained its Overweight rating on Advanced Micro Devices, signaling expectations the stock will outperform, and held firm on a $270 price target ahead of the chipmaker’s Feb. 3 earnings. The firm noted hyperscalers—the massive cloud providers—are already securing capacity through 2026, leaving AMD nearly sold out of server CPUs well into that…
Ovo’s £2.7m payout: Vulnerable customers waited 19 months for bill support

Ovo’s £2.7m payout: Vulnerable customers waited 19 months for bill support

London, Jan 23, 2026, 01:09 GMT Britain’s energy regulator has ordered Ovo to pay more than £2.7 million in compensation after thousands of vulnerable customers waited months for a government-backed electricity bill discount that should have arrived during the winter. (Ofgem) The ruling lands as households remain sensitive to energy costs and as regulators push suppliers to treat vulnerable customers…
23 January 2026
Carvana stock jumps 5% as Barclays lifts target and a February earnings test looms

Carvana stock jumps 5% as Barclays lifts target and a February earnings test looms

New York, Jan 22, 2026, 20:19 (ET) — Market closed Carvana Co shares jumped roughly 5% to $478.45 Thursday, beating gains in the broader U.S. market and several auto-retail rivals. (MarketWatch) Carvana has its next major event lined up. The company will release its fourth-quarter and full-year 2025 earnings after the market shuts on Feb. 18, followed by a conference…
Charles Schwab stock climbs after earnings as Forge vote clears a hurdle and Fed week nears

Charles Schwab stock climbs after earnings as Forge vote clears a hurdle and Fed week nears

New York, Jan 22, 2026, 19:59 (EST) — After-hours Charles Schwab shares climbed 2.2% Thursday, finishing at $104.05 in after-hours trading. Investors remained steady on the stock after the broker’s quarterly report. Schwab’s shares gained after the firm posted a jump in fourth-quarter profits, driven by stronger interest income and robust trading revenue as clients adjusted to shifting rate forecasts.…
Disney stock price stalls near $113 as proxy filing puts CEO pick in “early 2026” focus

Disney stock price stalls near $113 as proxy filing puts CEO pick in “early 2026” focus

New York, January 22, 2026, 19:56 EST — after-hours. Shares of The Walt Disney Company were mostly flat in after-hours trading Thursday following a proxy filing that set a virtual annual meeting for March 18. The filing also revealed the board plans to appoint its next CEO in early 2026. Disney’s stock edged up 4 cents, or roughly 0.04%, to…
Datadog stock jumps 6% after Stifel upgrade as investors brace for Feb. earnings and NYC investor day

Datadog stock jumps 6% after Stifel upgrade as investors brace for Feb. earnings and NYC investor day

New York, Jan 22, 2026, 20:20 (EST) — Market closed. Datadog shares jumped $7.79, or 6.3%, to close at $131.25 on Thursday. In after-hours trading, the stock edged up another 0.4% to $131.82. (MarketBeat) This move is significant as the cloud monitoring company gears up for a crucial two-day stretch next month packed with catalysts that might shift expectations. Datadog…

Stock Market Today

  • Oric Pharmaceuticals Shares Poised for 74% Upside as Biotech Innovation Draws Investor Attention
    January 23, 2026, 8:13 AM EST. Oric Pharmaceuticals (NASDAQ: ORIC) is gaining investor interest with a potential 74% upside from its current $12.05 share price, backed by partnerships with Pfizer, Bayer, and Johnson & Johnson. The clinical-stage biotech focuses on therapies addressing cancer treatment resistance, advancing candidates like ORIC-114 and ORIC-944 through early-stage trials. Despite a $1.17 billion market cap, Oric reports a negative EPS of -1.71 and free cash flow of -$70.7 million, reflecting typical high-risk biotech dynamics. With no dividends and a neutral RSI, stock momentum shows cautious optimism. Analysts rate ORIC with 14 buys and project a $21 average target price, suggesting substantial growth for investors able to tolerate the sector's inherent uncertainties.
Go toTop